Eli Lilly said it would invest $3 billion to ... Overall, the expanded facility would focus on manufacturing injectable medicines, device assembly and packaging for medicines across multiple ...

The expanded facility will focus on manufacturing injectable medicines, device assembly and packaging for medicines across multiple therapeutic areas. The news release says Lilly aims to advance ...

Eli Lilly is ... investment from Lilly, and the new tranche will take the tally to $1.7billion since 2020. It will boost the site's capacity for parenteral filling, device assembly, and packaging ...

Eli Lilly has unveiled a new partnership with diabetes device maker Dexcom to breathe new life into its diabetes division. The deal will see Dexcom's continuous glucose monitors integrated into ...